<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02889237</url>
  </required_header>
  <id_info>
    <org_study_id>NL46035.072.13</org_study_id>
    <nct_id>NCT02889237</nct_id>
  </id_info>
  <brief_title>Fracture Healing Assessed by HR-pQCT After Administration of Calcium and Vitamin D</brief_title>
  <official_title>Assessment of Fracture Healing by High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) and Bone Strength Analysis in Standard Care and After Immediate Administration of Calcium and Vitamin D Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VieCuri Medical Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VieCuri Medical Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as a single-blind RCT in 80 postmenopausal women to compare the effect
      of immediate administration of daily calcium supplementation (1000 mg calcium) or two daily
      dosages of calcium + vitamin D (1000 mg calcium + 880 IU vitamin D or 1000 mg calcium + 1760
      IU vitamin D) to standard care (administration of vitamin D3 12 weeks after fracture) in
      terms of calculated bone strength based on analysis of cortical and trabecular bone
      parameters using HR-pQCT, fracture healing and functional outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone strength</measure>
    <time_frame>1 year</time_frame>
    <description>Bone strength parameters will be assessed by HRpQCT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fracture healing</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome assessed by PRWE</measure>
    <time_frame>1 year</time_frame>
    <description>Functional outcome is assessed using Patient-Related Wrist Examination (PRWE) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome assessed by QuickDASH</measure>
    <time_frame>1 year</time_frame>
    <description>Functional outcome is assessed using QuickDASH questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome assessed using VAS for pain score</measure>
    <time_frame>1 year</time_frame>
    <description>Functional outcome is assessed using VAS for pain score on Visual Analogue Scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome assessed using range of motion</measure>
    <time_frame>1 year</time_frame>
    <description>Functional outcome is assessed by measuremt of range of motion of the fractured wrist</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Bone Fracture</condition>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Start of calcium and vitamin D3 supplementation according to standard care, i.e. 12 weeks after fracture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Immediate administration of daily calcium supplementation (1000 mg calcium)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium + low dose vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Immediate administration of daily calcium + low dose vitamin D supplementation (1000 mg calcium + 880 IU vitamin D).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium + high dose vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Immediate administration of daily calcium + high dose vitamin D supplementation (1000 mg calcium + 1760 IU vitamin D)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium</intervention_name>
    <description>Immediate administration of daily calcium supplementation for 12 weeks</description>
    <arm_group_label>Calcium</arm_group_label>
    <other_name>Cacit effervescent tablet '1000'</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium + low dose vitamin D</intervention_name>
    <description>Immediate administration of daily calcium and low dose vitamin D (1 sachet CaD 1000/880) supplementation for 12 weeks</description>
    <arm_group_label>Calcium + low dose vitamin D</arm_group_label>
    <other_name>CaD® sachet 1000/880</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium + high dose vitamin D</intervention_name>
    <description>Immediate administration of daily calcium and high dose vitamin D (2 sachets CaD 500/880) supplementation for 12 weeks</description>
    <arm_group_label>Calcium + high dose vitamin D</arm_group_label>
    <other_name>CaD® sachets 500/880</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postmenopausal women older than 50 years who present themselves in clinic with a
             distal radius fracture due to a trauma.

          -  Patients with a stable distal radius fracture treated by cast immobilization.

          -  Patients who understand the conditions of the study and are willing and able to comply
             with the scheduled biochemical and radiographic evaluations and the prescribed
             rehabilitation.

          -  Patients who signed the Ethics Committee approved specific Informed Consent Form prior
             to inclusion.

        Exclusion Criteria:

          -  Patients who underwent surgery of the wrist or radius on a previous occasion on the
             same side or who need surgery this time.

          -  Patients with active or suspected infection such as pneumonia or complicated urinary
             tract infection in the last 3 months.

          -  Patients with malignancy or a pathological fracture in the last 12 months.

          -  Patients with a neuromuscular or neurosensory deficit, e.g. Parkinson's disease, which
             would limit the ability to assess the performance during the healing period.

          -  Patients with known systemic or metabolic disorders leading to progressive bone
             deterioration, such as: hyperthyroidism, hyperparathyroidism, chronic kidney disease
             with eGFR&lt;30 ml/min, sarcoidosis, hypercalcemia,

          -  Patients with an active inflammatory disease during the last year such as rheumatoid
             arthritis, systemic lupus erythematous, inflammatory bowel disease, e.g. Crohn's
             disease and ulcerative colitis.

          -  The use of glucocorticoids during the last 12 months.

          -  Patients with an allergy to calcium, calcium carbonate, cholecalciferol, aspartame,
             citric-acid, lactose, dimethicone, methylcellulose, sorbic acid, macrogole,
             polyvidone, mannitol, orange flavour, natriumsaccharine, starch or sucrose.

          -  Patients, who as judged by the principal Investigator, are mentally incompetent or are
             unlikely to be compliant with the follow-up evaluation schedule.

          -  Patients with other severe concurrent joint involvements that can affect their
             outcome.

          -  Patients who are already selected for another trial concerning distal radius
             fractures.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J PW van den Bergh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VieCuri Medical Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>C E Wyers, PhD</last_name>
    <phone>+31773205555</phone>
    <email>cwyers@viecuri.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>F Heyer, MD</last_name>
    <phone>+31773205555</phone>
    <email>f.heyer@maastrichtuniversity.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VieCuri Medical Centre</name>
      <address>
        <city>Venlo</city>
        <state>Limburg</state>
        <zip>5912BL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F Heyer, MD</last_name>
      <phone>+31773205555</phone>
      <email>f.heyer@maastrichtuniversity.nl</email>
    </contact>
    <contact_backup>
      <last_name>C E Wyers, PhD</last_name>
      <phone>+31773205555</phone>
      <email>cwyers@viecuri.nl</email>
    </contact_backup>
    <investigator>
      <last_name>J PW van den Bergh, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2014</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2016</study_first_posted>
  <last_update_submitted>August 30, 2016</last_update_submitted>
  <last_update_submitted_qc>August 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VieCuri Medical Centre</investigator_affiliation>
    <investigator_full_name>Joop P.W. van den Bergh</investigator_full_name>
    <investigator_title>Prof. dr. J.P.W. van den Bergh, Endocrinologist</investigator_title>
  </responsible_party>
  <keyword>Fracture healing</keyword>
  <keyword>Calcium supplementation</keyword>
  <keyword>Vitamin D supplementation</keyword>
  <keyword>HR-pQCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

